H.R. 9077 is a bill that aims to direct the Director of the National Institutes of Health (NIH) and the Secretary of Health and Human Services (HHS) to assess hormone variability in women undergoing perimenopause and to evaluate the processes and effectiveness of hormone testing for these women. The goal is to improve understanding and management of hormonal changes during this transitional phase of a woman's life.
Media coverage has highlighted the bill as a significant step towards addressing women's health issues, particularly in relation to perimenopause. Supporters argue that it could lead to better diagnostic tools and treatments, ultimately improving the quality of life for many women experiencing hormonal fluctuations.
Critics have raised concerns that the bill may not address the underlying systemic issues in women's healthcare, such as access to care and the need for comprehensive research funding. Some believe that focusing solely on hormone testing may oversimplify the complexities of perimenopause and could lead to inadequate treatment options.
The bill H.R. 9077, which focuses on evaluating hormone variability and testing in women regarding perimenopause, has a notable connection to the sponsor, Hillary Scholten's top donor industry, Health Professionals, which contributed a substantial $80 million. This significant financial backing raises concerns about potential conflicts of interest, as the bill directly pertains to health issues that could benefit the very industry funding Scholten's campaign. The overlap between the bill's subject matter and the sponsor's donor base suggests that the interests of health professionals may unduly influence legislative outcomes, particularly in areas related to women's health and hormone therapies.
Additionally, while there is no direct lobbying activity reported from the Health Professionals sector specifically related to this bill, the presence of other industries involved in lobbying efforts indicates a broader landscape of financial interests that could intersect with the bill's objectives. Voters should be aware that the substantial donations from health professionals may create a perception of bias or favoritism towards the interests of these donors, potentially overshadowing the needs and perspectives of constituents seeking unbiased health policy reform.
These industries are both affected by this bill and among the sponsor's top donors.
| Industry | Match Type | Related Subject | Donations |
|---|---|---|---|
| Health Professionals (H01) | Sector | Health | $80,000,000 |
| Total from overlapping industries | $80,000,000 | ||
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| REFORM ACTION FUND | THE TOLMAN GROUP | $30,000 |
| VIASAT, INC. | GORMAN STRATEGY GROUP, TOO | $20,000 |
| PHOTONIS | LEWIS-BURKE ASSOCIATES, LLC | $20,000 |
| SOUTHWEST AIRLINES | THE MONDELLO GROUP LLC | $20,000 |
| HUBBARD BROADCASTING | STEPHEN WARD CONSULTING, LLC | $20,000 |
| ISTATION | THE MONDELLO GROUP LLC | undisclosed |
| LUMA ENERGY, LLC | TRUE COMPASS, LLC | undisclosed |
| SANTA FE FARMS, INC DBA ELEMENT6 DYNAMICS | STEPHEN WARD CONSULTING, LLC | undisclosed |
| LOUISIANA ENERGY SERVICES, LLC | STEPHEN WARD CONSULTING, LLC | undisclosed |
| CROSS COUNTRY HEALTHCARE, INC. | MILLER STRATEGIES, LLC | undisclosed |
| NUCOR CORPORATION | MILLER STRATEGIES, LLC | undisclosed |
| NEXUS HOSPICE OF THE HIGH DESERT LLC | MILLER STRATEGIES, LLC | undisclosed |
| TWG CADILLAC FORMULA 1 TEAM HOLDINGS, LLC | MILLER STRATEGIES, LLC | undisclosed |
| COSTAR GROUP, INC. | MILLER STRATEGIES, LLC | undisclosed |
| PADSPLIT, INC. | CONTINENTAL STRATEGY, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Hillary Scholten, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
